Your session is about to expire
← Back to Search
Physical Therapy for Osteoarthritis (TeMPO Trial)
N/A
Waitlist Available
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Knee pain of at least 21 days duration if traumatic; no minimum duration if non-traumatic
Physician diagnosis of meniscal tear
Must not have
Daily use of strong opioids
Inflammatory arthritis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will help us to understand how physical therapy works and what protocol is best for people with knee arthritis and meniscal tears.
Who is the study for?
This trial is for adults aged 45-85 with knee pain from a meniscal tear and osteoarthritis, confirmed by MRI or X-ray. Candidates must have had knee pain for at least 21 days if it's due to injury. Exclusions include inflammatory arthritis, recent knee surgery, pregnancy, MRI contraindications, strong opioid use, recent joint therapy, nursing home residents, dementia history or worker's compensation claimants.
What is being tested?
The TeMPO Trial compares four non-surgical physical therapy regimens to see which best reduces pain and improves function in people with meniscal tears and osteoarthritis. It includes in-clinic exercises, topical therapies, home exercises and motivational texts. One group will receive placebo treatments to identify effective therapy aspects.
What are the potential side effects?
Physical therapy side effects may include temporary increased joint pain or muscle soreness following treatment sessions. Topical therapies might cause skin irritation in some individuals.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have had knee pain for at least 21 days due to an injury, or any duration if not from an injury.
Select...
My doctor diagnosed me with a torn meniscus.
Select...
I am between 45 and 85 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I use strong painkillers every day.
Select...
I have inflammatory arthritis.
Select...
I do not speak English.
Select...
I have not had joint injections in the last 4 weeks.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3-12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Pain
Secondary study objectives
30-second sit to stand
Binary treatment failure indicator
Change in function
+5 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Experimental Treatment
Group I: 4. In-Clinic Exercise TherapyExperimental Treatment3 Interventions
Subjects in this arm will receive the TeMPO Home Exercise Program, SMS motivational messages to encourage them to adhere to the TeMPO Home Exercise Program and 14 in-clinic sessions with a trained physical therapist. The therapist will supervise the participant in a rigorous set of strengthening and stretching exercises.
Group II: 3. In-Clinic Topical TherapyExperimental Treatment3 Interventions
Subjects in this arm receive the TeMPO Home Exercise Program, motivational SMS messages to encourage them to adhere to the TeMPO Home Exercise Program, and 14 in-clinic sessions with a trained physical therapist. The therapist will apply topical therapies: ultrasound, gel, and manual therapy.
Group III: 2. Home Exercise Program + SMS MessagesExperimental Treatment2 Interventions
Subjects in this arm receive the TeMPO Home Exercise Program and motivational SMS messages to encourage them to adhere to the TeMPO Home Exercise regimen.
Group IV: 1. Home Exercise ProgramExperimental Treatment1 Intervention
The Home Exercise group receives the TeMPO Home Exercise Program (including a set of weights, a DVD showing how to complete the TeMPO exercises, and a pamphlet outlining instructions on how to complete the exercises and how often should they be done).
Find a Location
Who is running the clinical trial?
State University of New York at BuffaloOTHER
268 Previous Clinical Trials
51,445 Total Patients Enrolled
1 Trials studying Osteoarthritis
300 Patients Enrolled for Osteoarthritis
Brigham and Women's HospitalLead Sponsor
1,664 Previous Clinical Trials
11,834,107 Total Patients Enrolled
16 Trials studying Osteoarthritis
29,031 Patients Enrolled for Osteoarthritis
National Institutes of Health (NIH)NIH
2,810 Previous Clinical Trials
8,158,753 Total Patients Enrolled
20 Trials studying Osteoarthritis
3,957 Patients Enrolled for Osteoarthritis
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I use strong painkillers every day.I have had knee pain for at least 21 days due to an injury, or any duration if not from an injury.My doctor diagnosed me with a torn meniscus.I have inflammatory arthritis.I do not speak English.I am between 45 and 85 years old.I have not had joint injections in the last 4 weeks.I have had knee surgery, including APM or TKR, on my affected knee.I am between 45 and 85 years old.
Research Study Groups:
This trial has the following groups:- Group 1: 4. In-Clinic Exercise Therapy
- Group 2: 3. In-Clinic Topical Therapy
- Group 3: 1. Home Exercise Program
- Group 4: 2. Home Exercise Program + SMS Messages
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger